Brucellosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 31: Line 31:
===Pathogenesis===
===Pathogenesis===
*Virulent Brucella organisms can infect both nonphagocytic and phagocytic cells.  
*Virulent Brucella organisms can infect both nonphagocytic and phagocytic cells.  
*Within nonphagocytic cells, brucellae tend to localize in the rough endoplasmic reticulum.  
*When Brucella enters the body white blood cells (WBC) fagocitate the pathogen, particularly neutrophils and macrophages.
*In polymorphonuclear or mononuclear phagocytic cells, they use a number of mechanisms for avoiding or suppressing bactericidal responses.
**WBC transports the pathogen via hematological and lymphatic routes to different organs, particulary of the reticuloendothelial system (RES).
*The lipopolysaccharide of smooth phase strains (S-LPS) probably plays a substantial role in intracellular survival, as smooth organisms survive much more effectively than nonsmooth ones.  
**They multiple themselves within the vacuoles of the phagocytes without being destructed.
*S-LPS is the main antigen responsible for containing protection against infection in passive transfer experiments with monoclonal and polyclonal antibodies.  
*Different Brucella species are classified as smooth and rough lipopolysaccharide phenotypes.
**The protection is usually short-term and incomplete.  
**Smooth lipopolysaccharides (S-LPS):
***B. abortus, B. melitensis, B. suis and B. neotoma
***S-LPS are more virulent than R-LPS
***S-LPS survive much more effectively than nonsmooth ones
**Rough lipopolysaccharides (R-LPS):
***B. ovis and B. canis
*In polymorphonuclear or mononuclear phagocytic cells, Brucella spp. uses a number of mechanisms for avoiding or suppressing bactericidal responses:
**Lipopolysaccharide and outer membrane proteins probably play a substantial role in intracellular survival.  
***This may be due to the mannose and integrins receptors.
**Brucella stays within the cells because it inhibits cellular mechanisms of programmed cell death (apoptosis).
**The survival of Brucella within the cells has been associated with:
***Synthesis of antioxidant enzymes
***Production of guanosine 5 monophosphate (GMP)
**** GMP inhibits: phagolysosome fusion, degranulation and activation of the myelo-peroxidase-halide system, and production of tumor necrosis factor.
***Synthesis of proteins of molecular weight 17, 24, 28, 60, and 62 kDa.
****The 24 kDa protein is acid-induced, and its production correlates with bacterial survival under acidic conditions (<pH4).
****The 17 and 28 kDa proteins are apparently specifically induced by macrophages and correlated with intracellular survival.
*The elimination of virulent Brucella depends on activated macrophages and hence requires development of Th1 type cell-mediated responses to protein antigens.
*The elimination of virulent Brucella depends on activated macrophages and hence requires development of Th1 type cell-mediated responses to protein antigens.
*An important determinant of virulence is the production of adenine and guanine monophosphate, which inhibit phagolysosome fusion; degranulation and activation of the myelo-peroxidase-halide system; and production of tumor necrosis factor.
*Survival within macrophages is associated with the synthesis of proteins of molecular weight 17, 24, 28, 60, and 62 kDa.
**The 24 kDa protein is acid-induced, and its production correlates with bacterial survival under acidic conditions (<pH4).
**The 17 and 28 kDa proteins are apparently specifically induced by macrophages and correlated with intracellular survival.
*High iron concentrations promote the killing of Brucella, probably by favoring production of hydroxylamine and hydroxyl radical.
*High iron concentrations promote the killing of Brucella, probably by favoring production of hydroxylamine and hydroxyl radical.
*The mechanisms of pathogenesis of Brucella infection in its natural host species and in humans are still not completely understood, and further studies are needed.<ref name="pmid9204307">{{cite journal| author=Corbel MJ| title=Brucellosis: an overview. | journal=Emerg Infect Dis | year= 1997 | volume= 3 | issue= 2 | pages= 213-21 | pmid=9204307 | doi=10.3201/eid0302.970219 | pmc=PMC2627605 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9204307  }} </ref>
*The mechanisms of pathogenesis of Brucella infection in its natural host species and in humans are still not completely understood, and further studies are needed.<ref name="pmid9204307">{{cite journal| author=Corbel MJ| title=Brucellosis: an overview. | journal=Emerg Infect Dis | year= 1997 | volume= 3 | issue= 2 | pages= 213-21 | pmid=9204307 | doi=10.3201/eid0302.970219 | pmc=PMC2627605 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9204307  }} </ref><ref name="c">Brucelosis. Wikipedia. https://es.wikipedia.org/wiki/Brucelosis. Accessed on February 2, 2016</ref>


===Microscopic Pathology===
===Microscopic Pathology===

Revision as of 19:28, 2 February 2016

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis pathophysiology

CDC on Brucellosis pathophysiology

Brucellosis pathophysiology in the news

Blogs on Brucellosis pathophysiology

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza Lukac

Pathophysiology

Transmission

  • Brucella spp. are primarily passed among animals, and they cause disease in many different vertebrates.
  • Various Brucella species affect sheep, goats, cattle, deer, elk, pigs, dogs, american bishop and several other animals.
  • Humans are generally infected in one of three ways:
    • Eating undercooked meat or consuming unpasteurized/raw dairy products
      • The most common way to be infected is by eating or drinking unpasteurized/raw dairy products.
      • When sheep, goats, cows, or camels are infected, their milk becomes contaminated with the bacteria.
      • If the milk from infected animals is not pasteurized, the infection will be transmitted to people who consume the milk and/or cheese products.
    • Breathing in the bacteria that cause brucellosis (inhalation)
      • This risk is generally greater for people in laboratories that work with the bacteria.
      • Slaughterhouse and meat-packing employees have also been known to be exposed to the bacteria and ultimately become infected.
    • Bacteria entering the body through skin wounds or mucous membranes
      • Bacteria can also enter wounds in the skin/mucous membranes through contact with infected animals.
      • This poses a problem for workers who have close contact with animals or animal excretions (newborn animals, fetuses, and excretions that may result from birth).
      • Such workers may include:
        • Slaughterhouse workers
        • Meat-packing plant employees
        • Veterinarians
  • Person-to-person spread of brucellosis is extremely rare.
  • Infected mothers who are breast-feeding may transmit the infection to their infants.
  • Sexual transmission has been rarely reported.
  • While uncommon, transmission may also occur via tissue transplantation or blood transfusions.[1]
  • Liver:

Pathogenesis

  • Virulent Brucella organisms can infect both nonphagocytic and phagocytic cells.
  • When Brucella enters the body white blood cells (WBC) fagocitate the pathogen, particularly neutrophils and macrophages.
    • WBC transports the pathogen via hematological and lymphatic routes to different organs, particulary of the reticuloendothelial system (RES).
    • They multiple themselves within the vacuoles of the phagocytes without being destructed.
  • Different Brucella species are classified as smooth and rough lipopolysaccharide phenotypes.
    • Smooth lipopolysaccharides (S-LPS):
      • B. abortus, B. melitensis, B. suis and B. neotoma
      • S-LPS are more virulent than R-LPS
      • S-LPS survive much more effectively than nonsmooth ones
    • Rough lipopolysaccharides (R-LPS):
      • B. ovis and B. canis
  • In polymorphonuclear or mononuclear phagocytic cells, Brucella spp. uses a number of mechanisms for avoiding or suppressing bactericidal responses:
    • Lipopolysaccharide and outer membrane proteins probably play a substantial role in intracellular survival.
      • This may be due to the mannose and integrins receptors.
    • Brucella stays within the cells because it inhibits cellular mechanisms of programmed cell death (apoptosis).
    • The survival of Brucella within the cells has been associated with:
      • Synthesis of antioxidant enzymes
      • Production of guanosine 5 monophosphate (GMP)
        • GMP inhibits: phagolysosome fusion, degranulation and activation of the myelo-peroxidase-halide system, and production of tumor necrosis factor.
      • Synthesis of proteins of molecular weight 17, 24, 28, 60, and 62 kDa.
        • The 24 kDa protein is acid-induced, and its production correlates with bacterial survival under acidic conditions (<pH4).
        • The 17 and 28 kDa proteins are apparently specifically induced by macrophages and correlated with intracellular survival.
  • The elimination of virulent Brucella depends on activated macrophages and hence requires development of Th1 type cell-mediated responses to protein antigens.
  • High iron concentrations promote the killing of Brucella, probably by favoring production of hydroxylamine and hydroxyl radical.
  • The mechanisms of pathogenesis of Brucella infection in its natural host species and in humans are still not completely understood, and further studies are needed.[2][3]

Microscopic Pathology

Brucella spp. are poorly staining, small gram-negative coccobacilli (0.5-0.7 x 0.6-1.5 µm), and are seen mostly as single cells and appearing like “fine sand”.
Histopathology of guinea pig liver in experimental Brucella suis infection. Granuloma with necrosis
  • Brucella spp. are gram-negative in their staining morphology.
  • Brucella spp. are poorly staining, small gram-negative coccobacilli (0.5-0.7 x 0.6-1.5 µm).
  • Brucella spp. are seen mostly as single cells and appearing like “fine sand”.[4]
  • On microscopic histopathological analysis of the liver, common findings are:
    • Granulomas with centrilobular necrosis or focal necrosis and parenchyma destruction.[5]

Reference

  1. Brucellosis. CDC. http://www.cdc.gov/brucellosis/transmission/index.html. Accessed on January 29, 2016
  2. Corbel MJ (1997). "Brucellosis: an overview". Emerg Infect Dis. 3 (2): 213–21. doi:10.3201/eid0302.970219. PMC 2627605. PMID 9204307.
  3. Brucelosis. Wikipedia. https://es.wikipedia.org/wiki/Brucelosis. Accessed on February 2, 2016
  4. Brucellosis. Wikipedia. https://en.wikipedia.org/wiki/Brucellosis. Accessed on January 29, 2016
  5. Hunt A, Bothwell P. Histological findings in human brucellosis. J Clin Pathol. 1967; 20: 267-272

Template:WH Template:WS